NCT07102589 SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
| NCT ID | NCT07102589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-06-01 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational study that evaluates whether the Shuttle Walking Test (SWT) can predict postoperative symptoms, particularly dyspnea, in patients with chronic respiratory diseases undergoing lung resection. Currently, tools such as DLCO or cardiopulmonary exercise testing (CPET) are used to assess surgical risk and exercise capacity before lung surgery. However, these tests are not always accessible due to equipment limitations or long waiting times. The SWT is a simpler, safer, and more cost-effective alternative that has been recently recognized as a new medical technology in Korea for evaluating exercise capacity. In this study, patients with chronic lung diseases (such as COPD, ILD, or bronchiectasis) who are scheduled to undergo lung resection will perform the SWT before surgery. Their symptoms and quality of life will be assessed through questionnaires before and three months after the surgery. The goal is to determine whether SWT results can help predict postoperative dyspnea and provide useful information for preoperative risk stratification.
Eligibility Criteria
Inclusion Criteria: * \- Age ≥ 40 years * Scheduled for surgical lung resection (e.g., for lung cancer or benign tumor) * Diagnosis of chronic respiratory disease (COPD, ILD, or bronchiectasis) * Able to perform Shuttle Walking Test (ISWT + ESWT) before surgery * Able to complete pre- and postoperative symptom questionnaires (dyspnea, EQ-5D) Exclusion Criteria: * \- Illiteracy or inability to read study materials * Inability to communicate in Korean * Decline or withdraw consent * Severe lower limb disability interfering with walking (e.g., fracture, paralysis)
Frequently Asked Questions
Who can join the NCT07102589 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07102589 currently recruiting?
Yes, NCT07102589 is actively recruiting participants. Visit ClinicalTrials.gov or contact Seoul National University Bundang Hospital to inquire about joining.
Where is the NCT07102589 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT07102589 clinical trial?
NCT07102589 is sponsored by Seoul National University Bundang Hospital. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.